| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.03 |